You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Sertraline maintenance treatment reduced relapse and dropouts in post-traumatic stress disorder

https://doi.org/10.1136/ebm.7.5.149

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2001) Am J Psychiatry 158, 1974; Davidson J, Pearlstein T, Londborg P, et al.. Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.. Dec;. :. –81.
    OpenUrlCrossRefPubMedWeb of Science

    
 
 QUESTION: In patients who have post-traumatic stress disorder (PTSD) and have responded to continuation sertraline treatment, does maintenance sertraline treatment reduce relapse?

    Design

    Randomised (unclear allocation concealment*), blinded (unclear),* placebo controlled trial with 28 weeks of follow up.

    Setting

    24 centres in the US.

    Patients

    96 patients who were 21 to 69 years of age (mean age 43y y, 70% women); met the Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised, criteria for PTSD; had PTSD symptoms for > 6 months (mean duration 13 y) and a total severity score ≥ 50 on the Clinician-Administered PTSD Scale (CAPS) part 2; and met responder criteria (Clinical Global Impression [CGI] improvement score ≤ 2 and ≥ 30% improvement in total severity score on CAPS part 2) after 24 weeks of sertraline. Exclusion criteria included bipolar disorder, schizophrenia, organic mental disorder, primary diagnosis of major depression or anxiety, and substance …

    View Full Text

    Footnotes

    • Source of funding: Pfizer.

    • For correspondence: Dr J Davidson, Duke University Medical Center, Durham, North Carolina, USA. jonathan.davidson{at}duke.edu.

    • Abstract and commentary also appear in Evidence-Based Mental Health.

    • ↵* See glossary.